Imad Saad-Eldine Farrukh
Hearing Aid Provider in Salt Lake City, UT
License number
Utah 180183-8914
Issued Date
Jan 25, 1994
Expiration Date
May 31, 2001
Category
xControlled Substance Handler
Type
Controlled Substance Handler Individual
Address
Address
Salt Lake City, UT
Personal information
See more information about Imad Saad-Eldine Farrukh at radaris.comName
Address
Phone
165 Edgecombe Dr, Salt Lake Cty, UT 84103
165 E Edgecombe Dr, Salt Lake City, UT 84103
S Salt Lake, UT
1990 7800, West Jordan, UT 84088
165 Edgecombe Dr, Salt Lake Cty, UT 84103
Professional information
Methods For Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation And Adult Respiratory Distress Syndrome
US Patent:
6187767, Feb 13, 2001
Filed:
May 14, 1999
Appl. No.:
9/311306
Inventors:
Barbara A. Araneo - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
International Classification:
A61K 3156
US Classification:
514178
Abstract:
The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
Methods For Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation And Respiratory Distress Syndrome
US Patent:
5977095, Nov 2, 1999
Filed:
Jun 5, 1997
Appl. No.:
8/870234
Inventors:
Barbara A. Araneo - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
International Classification:
A61K 3156
US Classification:
514178
Abstract:
The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (bums), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing, or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
Methods For Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation And Adult Respiratory Distress Syndrome
US Patent:
5846963, Dec 8, 1998
Filed:
Aug 18, 1995
Appl. No.:
8/516540
Inventors:
Barbara A. Araneo - Salt Lake City UT
Urszula Orlinska - Salt Lake City UT
Imad S. Farrukh - Salt Lake City UT
Urszula Orlinska - Salt Lake City UT
Imad S. Farrukh - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
International Classification:
A61K 3156
US Classification:
514178
Abstract:
The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering dehydroepiandrosterone-3-sulfate (DHEAS).
Methods For Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation And Adult Respiratory Distress Syndrome
US Patent:
6150348, Nov 21, 2000
Filed:
May 14, 1999
Appl. No.:
9/311282
Inventors:
Barbara A. Araneo - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Raymond A. Daynes - Park City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
International Classification:
A61K 3156
US Classification:
514178
Abstract:
The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
Methods For Preventing Progressive Tissue Necrosis, Reperfusion Injury, Bacterial Translocation And Adult Respiratory Distress Syndrome
US Patent:
5753640, May 19, 1998
Filed:
Dec 29, 1995
Appl. No.:
8/580716
Inventors:
Barbara A. Araneo - Salt Lake City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Urszula Orlinska - Hockessin DE
Imad S. Farrukh - Salt Lake City UT
Assignee:
University of Utah Research Foundation - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
Pharmadigm, Inc. - Salt Lake City UT
International Classification:
A61K 3156
US Classification:
514178
Abstract:
The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering dehydroepiandrosterone-3-sulfate (DHEAS), DHEA or a DHEA congener.